Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer
-
Published:2024-05
Issue:
Volume:
Page:
-
ISSN:2588-9311
-
Container-title:European Urology Oncology
-
language:en
-
Short-container-title:European Urology Oncology
Author:
Wu Zhouliang, Zhao Gangjian, Zhang Zhe, Shen Chong, Wang Lili, Xu Guoping, Zhao Yang, Liang Rui, Li Changping, Liu Huanhuan, Wang Hongmei, Dong Hua, Fu Huaying, Li Man, Li Hongjun, Zhuang Yan, Da La, Huang Shiwang, Jia Kaipeng, Chen Houyuan, Bai Yiduo, Guo Shizheng, Cheng Huanqing, Wang Huina, Wang Haitao, Niu Yuanjie, Hu HailongORCID
Reference29 articles.
1. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003 2. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2023 3. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial;Bellmunt;Lancet Oncol,2021 4. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study;Necchi;J Clin Oncol,2018 5. Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial;Powles;Nat Med,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|